Tag: Obesity drug production

Browse exclusive Tags!

Novo Nordisk to Invest $2.3B in French Production Expansion, France

Novo Nordisk invests $2.3B to expand obesity drug production in France, creating 500 new jobs and addressing the global demand for treatments.

Popular

Subscribe

spot_imgspot_img